Influenza Medication Market Size, Share, Trends & Industry Analysis, By Treatment (Baloxavir marboxil, Oseltamivir phosphate, Others), By Influenza Type (Influenza A, Influenza B), By Route of Administration (Oral, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2032

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI101843

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Overview of Influenza Epidemiology
2. Analysis of Disease Burden of Influenza, By Key Regions
3. New Product Launches
4. Pipeline Analysis
5. Analysis of the Impact of the Launch of Generics on the Influenza Medication Market
6. Key Industry Developments
Global Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Treatment
  1. Baloxavir marboxil
  2. Oseltamivir phosphate
  3. Others
3. Market Analysis, Insights and Forecast – By Influenza Type
  1. Influenza A
  2. Influenza B
4. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Others
5. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
6. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Treatment
  1. Baloxavir marboxil
  2. Oseltamivir phosphate
  3. Others
3. Market Analysis – By Influenza Type
  1. Influenza A
  2. Influenza B
4. Market Analysis – By Route of Administration
  1. Oral
  2. Others
5. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
6. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Treatment
  1. Baloxavir marboxil
  2. Oseltamivir phosphate
  3. Others
3. Market Analysis – By Influenza Type
  1. Influenza A
  2. Influenza B
4. Market Analysis – By Route of Administration
  1. Oral
  2. Others
5. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
6. Market Analysis – By Country/Sub-Region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Treatment
  1. Baloxavir marboxil
  2. Oseltamivir phosphate
  3. Others
3. Market Analysis – By Influenza Type
  1. Influenza A
  2. Influenza B
4. Market Analysis – By Route of Administration
  1. Oral
  2. Others
5. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
6. Market Analysis – By Country/Sub-Region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Treatment
  1. Baloxavir marboxil
  2. Oseltamivir phosphate
  3. Others
3. Market Analysis – By Influenza Type
  1. Influenza A
  2. Influenza B
4. Market Analysis – By Route of Administration
  1. Oral
  2. Others
5. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
6. Market Analysis – By Country/Sub-Region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Influenza Medication Market Analysis, Insights and Forecast, 2015-2026
1. Key Findings / Summary
2. Market Analysis – By Treatment
  1. Baloxavir marboxil
  2. Oseltamivir phosphate
  3. Others
3. Market Analysis – By Influenza Type
  1. Influenza A
  2. Influenza B
4. Market Analysis – By Route of Administration
  1. Oral
  2. Others
5. Market Analysis – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
  4. Others
6. Market Analysis – By Country/ Sub-Region
  1. GCC Countries
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Key Industry Developments
2. Global Market Share Analysis (2018)
3. Competition Dashboard
4. Comparative Analysis – Major Players
5. Company Profiles
  1. Genentech, Inc.
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  2. Shionogi & Co., Ltd.
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  3. Seqirus (CSL)
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  4. BIOCRYST PHARMACEUTICALS, INC.
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  5. GlaxoSmithKline plc
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  6. Lupin Limited
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  7. Teva Pharmaceutical Industries Ltd.
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  8. Zydus Pharmaceuticals, Inc. (Zydus Cadila)
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  9. Amneal Pharmaceuticals LLC
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  10. Macleods Pharmaceuticals Ltd.
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  11. Alvogen
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
  12. Others
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based On Availability)
Strategic Recommendations

Read Less

List of Figures

Figure 1: Global Influenza Medication Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2: Global Influenza Medication Market Value Share (%), by Treatment, 2018 & 2026

Figure 3: Global Influenza Medication Market Forecast (US$ Mn), by Baloxavir marboxil, 2015-2026

Figure 4: Global Influenza Medication Market Forecast (US$ Mn), by Oseltamivir phosphate, 2015-2026

Figure 5: Global Influenza Medication Market Forecast (US$ Mn), by Others, 2015-2026

Figure 6: Global Influenza Medication Market Value Share (%), by Influenza Type, 2018 & 2026

Figure 7: Global Influenza Medication Market Forecast (US$ Mn), by Influenza A, 2015-2026

Figure 8: Global Influenza Medication Market Forecast (US$ Mn), by Influenza B, 2015-2026

Figure 9: Global Influenza Medication Market Value Share (%), by Route of Administration, 2018 & 2026

Figure 10: Global Influenza Medication Market Forecast (US$ Mn), by Oral, 2015-2026

Figure 11: Global Influenza Medication Market Forecast (US$ Mn), by Others, 2015-2026

Figure 12: Global Influenza Medication Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 13: Global Influenza Medication Market Forecast (US$ Mn), by Hospital Pharmacies, 2015-2026

Figure 14: Global Influenza Medication Market Forecast (US$ Mn), by Retail Pharmacies, 2015-2026

Figure 15: Global Influenza Medication Market Forecast (US$ Mn), by Online Pharmacies, 2015-2026

Figure 16: Global Influenza Medication Market Forecast (US$ Mn), by Others, 2015-2026

Figure 17: Global Influenza Medication Market Value (US$ Mn), by Region, 2018 & 2026

Figure 18: North America Influenza Medication Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 19: North America Influenza Medication Market Value Share (%), by Treatment, 2018

Figure 20: North America Influenza Medication Market Value (US$ Mn), by Influenza Type, 2018 & 2026

Figure 21: North America Influenza Medication Market Value Share (%), by Influenza Type, 2018

Figure 22: North America Influenza Medication Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 23: North America Influenza Medication Market Value Share (%), by Route of Administration, 2018

Figure 24: North America Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 25: North America Influenza Medication Market Value Share (%), by Distribution Channel, 2018

Figure 26: North America Influenza Medication Market Value (US$ Mn), By Country, 2018 & 2026

Figure 27: North America Influenza Medication Market Value Share (%), By Country, 2018

Figure 28: Europe Influenza Medication Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 29: Europe Influenza Medication Market Value Share (%), by Treatment, 2018

Figure 30: Europe Influenza Medication Market Value (US$ Mn), by Influenza Type, 2018 & 2026

Figure 31: Europe Influenza Medication Market Value Share (%), by Influenza Type, 2018

Figure 32: Europe Influenza Medication Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 33: Europe Influenza Medication Market Value Share (%), by Route of Administration, 2018

Figure 34: Europe Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 35: Europe Influenza Medication Market Value Share (%), by Distribution Channel, 2018

Figure 36: Europe Influenza Medication Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 37: Europe Influenza Medication Market Value Share (%), By Country/ Sub-region, 2018

Figure 38: Asia Pacific Influenza Medication Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 39: Asia Pacific Influenza Medication Market Value Share (%), by Treatment, 2018

Figure 40: Asia Pacific Influenza Medication Market Value (US$ Mn), by Influenza Type, 2018 & 2026

Figure 41: Asia Pacific Influenza Medication Market Value Share (%), by Influenza Type, 2018

Figure 42: Asia Pacific Influenza Medication Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 43: Asia Pacific Influenza Medication Market Value Share (%), by Route of Administration, 2018

Figure 44: Asia Pacific Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 45: Asia Pacific Influenza Medication Market Value Share (%), by Distribution Channel, 2018

Figure 46: Asia Pacific Influenza Medication Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 47: Asia Pacific Influenza Medication Market Value Share (%), By Country/ Sub-region, 2018

Figure 48: Latin America Influenza Medication Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 49: Latin America Influenza Medication Market Value Share (%), by Treatment, 2018

Figure 50: Latin America Influenza Medication Market Value (US$ Mn), by Influenza Type, 2018 & 2026

Figure 51: Latin America Influenza Medication Market Value Share (%), by Influenza Type, 2018

Figure 52: Latin America Influenza Medication Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 53: Latin America Influenza Medication Market Value Share (%), by Route of Administration, 2018

Figure 54: Latin America Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 55: Latin America Influenza Medication Market Value Share (%), by Distribution Channel, 2018

Figure 56: Latin America Influenza Medication Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 57: Latin America Influenza Medication Market Value Share (%), By Country/ Sub-region, 2018

Figure 58: Middle East & Africa Influenza Medication Market Value (US$ Mn), by Treatment, 2018 & 2026

Figure 59: Middle East & Africa Influenza Medication Market Value Share (%), by Treatment, 2018

Figure 60: Middle East & Africa Influenza Medication Market Value (US$ Mn), by Influenza Type, 2018 & 2026

Figure 61: Middle East & Africa Influenza Medication Market Value Share (%), by Influenza Type, 2018

Figure 62: Middle East & Africa Influenza Medication Market Value (US$ Mn), by Route of Administration, 2018 & 2026

Figure 63: Middle East & Africa Influenza Medication Market Value Share (%), by Route of Administration, 2018

Figure 64: Middle East & Africa Influenza Medication Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 65: Middle East & Africa Influenza Medication Market Value Share (%), by Distribution Channel, 2018

Figure 66: Middle East & Africa Influenza Medication Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 67: Middle East & Africa Influenza Medication Market Value Share (%), By Country/ Sub-region, 2018

Figure 68: Global Influenza Medication Market Share (%), By Company, 2018

List of Tables

Table 1: Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 2: Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2015–2026

Table 3: Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015–2026

Table 4: Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 5: Global Influenza Medication Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 6: North America Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 7: North America Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2015-2026

Table 8: North America Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 9: North America Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 10: North America Influenza Medication Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 11: Europe Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 12: Europe Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2015-2026

Table 13: Europe Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 14: Europe Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 15: Europe Influenza Medication Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 16: Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 17: Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2015-2026

Table 18: Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 19: Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20: Asia Pacific Influenza Medication Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21: Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 22: Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2015-2026

Table 23: Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 24: Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 25: Latin America Influenza Medication Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 26: Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, by Treatment, 2015-2026

Table 27: Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, by Influenza Type, 2015-2026

Table 28: Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, by Route of Administration, 2015-2026

Table 29: Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 30: Middle East & Africa Influenza Medication Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

REPORT UPDATE
IN PROCESS
STUDY PERIOD: 2019-2032
(In Process)
BASE YEAR:2023
(In Process)

Consulting Services

Healthcare Clients

Related Reports

Get in Touch with Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
[email protected]